SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Medium-term Notes
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Medium-term Notes of $73.01 thousand as of 2022-12-31, per its 10-K/A filed 2024-09-04.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:MediumTermNotes · last filed 2024-09-04
- 2022-12-31: Medium-term Notes $73.01K.
- 2021-03-09: Medium-term Notes $73.01K.
- 2020-05-15: Medium-term Notes $62.50K.
| Period end | Medium-term Notes |
|---|---|
| 2022-12-31 | $73.01K 10-K/A · filed 2024-09-04 |
| 2021-03-09 | $73.01K 10-K/A · filed 2024-09-04 |
| 2020-05-15 | $62.50K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |